<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160131026279N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-18</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of rehabilitation and galvanic vestibular stimulation on the treatment of persistent postural-perceptual dizziness (PPPD)</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effectiveness of vestibular rehabilitation with and without galvanic vestibular stimulation on dizziness and postural control in patients with persistent postural-perceptual dizziness: A randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>27</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72572</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Method of randomization: block
Unit of randomization: size 3, three equal groups
Tools used in randomization: Random allocation software
Random sequence generation: Random allocation software
Allocation concealment: none
Patients will be allocated to groups indicated in the sequence in order of enrolling in the study. For example, in a sequence of group 3, group 1, and group 2, the first patient will be allocated to group 3, and so on.</study_design>
      <phase>N/A</phase>
      <hc_freetext>persistent postural-perceptual dizziness.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1 (VRT): receiving individualized vestibular rehabilitation 30 minutes twice a day for 6 weeks, in which the rehabilitation exercises are planned based on the patient's complaints and test results. Exercises include adaptation, gaze stabilization, and habituations which involve eye, head, and body movements. Intervention 2: Intervention group 2 (VRT+GVS): receiving individualized vestibular rehabilitation 30 minutes twice a day for 6 weeks and noisy GVS 30 minutes, one session per week for six weeks, in which the rehabilitation exercises are planned based on the patient's complaints and test results. Exercises include adaptation, gaze stabilization, and habituations which involve eye, head, and body movements. The electrical stimulation (random bandwidth of less than 30 Hz, bipolar current, and sub-threshold intensity) is applied through electrodes placed over mastoid processes. Intervention 3: Intervention group 3 (nGVS): receiving noisy GVS 30 minutes, one session per week for six weeks, in which the electrical stimulation (random bandwidth of less than 30 Hz, bipolar current, and sub-threshold intensity) is applied through electrodes placed over mastoid processes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data files containing all data will be uploaded via https://zenodo.org/ after the deidentification of participants, named "Dataset of Comparing the effectiveness of vestibular rehabilitation with and without galvanic vestibular stimulation on dizziness and postural control in patients with persistent postural-perceptual dizziness: A randomized controlled trial"

When:
After the study ends and the paper is published for one year at least

To whom:
Public

Conditions:
None

Where to obtain:
https://zenodo.org/

How to obtain:
Searching the file name or author names in https://zenodo.org/ and downloading the file.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mansoureh Adel Ghahraman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6511111489</zip>
        <telephone>+98 21 7753 4364</telephone>
        <email>madel@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mansoureh Adel Ghahraman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enghelab Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6511111489</zip>
        <telephone>+98 21 7753 4364</telephone>
        <email>madel@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iraq</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosed with PPPD according to Barany Society Committee diagnostic criteria. The                  symptoms of 3 months duration or more
No previous experience with vestibular exercises or rehabilitation
18 to 65 years of age
Lack of previous drug or alcohol addiction
No Current neurological disorder
Lack of drug consumption that results in suppressing vestibular system compensation
Not pregnant woman
No current vestibular disease coexist with PPPD patients
Lack of musculoskeletal issues that impair gait
Absence of cognitive impairment
No vestibular paroxysmia</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Fatigue or unwillingness of the patient to continue the test
Catch a disease affecting the vestibular system during the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H81.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other disorders of vestibular function</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1 (VRT): receiving individualized vestibular rehabilitation 30 minutes twice a day for 6 weeks, in which the rehabilitation exercises are planned based on the patient's complaints and test results. Exercises include adaptation, gaze stabilization, and habituations which involve eye, head, and body movements.</i_keyword>
      <i_keyword>Intervention group 2 (VRT+GVS): receiving individualized vestibular rehabilitation 30 minutes twice a day for 6 weeks and noisy GVS 30 minutes, one session per week for six weeks, in which the rehabilitation exercises are planned based on the patient's complaints and test results. Exercises include adaptation, gaze stabilization, and habituations which involve eye, head, and body movements. The electrical stimulation (random bandwidth of less than 30 Hz, bipolar current, and sub-threshold intensity) is applied through electrodes placed over mastoid processes.</i_keyword>
      <i_keyword>Intervention group 3 (nGVS): receiving noisy GVS 30 minutes, one session per week for six weeks, in which the electrical stimulation (random bandwidth of less than 30 Hz, bipolar current, and sub-threshold intensity) is applied through electrodes placed over mastoid processes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Path length (anteroposterior and mediolateral). Timepoint: Before and after intervention. Method of measurement: The Modified Clinical Test of Sensory Interaction on Balance.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Angle of path length. Timepoint: Before and after intervention. Method of measurement: The Modified Clinical Test of Sensory Interaction on Balance.</sec_outcome>
      <sec_outcome>Dizziness handicap inventory score. Timepoint: Before and after intervention. Method of measurement: Dizziness handicap inventory.</sec_outcome>
      <sec_outcome>Hospital Anxiety and Depression Scale score. Timepoint: Before and after intervention. Method of measurement: Hospital Anxiety and Depression Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-09-03</approval_date>
        <contact_name>School of Nursing and Midwifery &amp; Rehabilitation - Tehran University of Medical Sciences</contact_name>
        <contact_address>Enghelab Ave. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
